Press Release, EIN Presswire Örn Almarsson 12/16/25 Press Release, EIN Presswire Örn Almarsson 12/16/25 ‘Axelyf Appoints Daniel Frímannsson, Ph.D., Head of Nucleic Acid Technologies & Biology and Leslie Williams to Board’ Read More Press Release, EIN Presswire Örn Almarsson 8/19/25 Press Release, EIN Presswire Örn Almarsson 8/19/25 ‘Axelyf Closes Seed Financing to Advance Next-Generation RNA-LNP Therapeutics’ Read More Media Örn Almarsson 5/27/25 Media Örn Almarsson 5/27/25 'Developing and delivering mRNA lipid nanoparticle therapeutics’ - BioTechniques Interview with Örn Read More Media Örn Almarsson 3/28/25 Media Örn Almarsson 3/28/25 Örn Almarsson interviewed by Lucia Donajová from Synthace Read More Media Örn Almarsson 2/3/25 Media Örn Almarsson 2/3/25 Örn Almarsson joins Charles Spence on ‘A Dose of Reality’ podcast Read More Media Örn Almarsson 9/13/24 Media Örn Almarsson 9/13/24 Örn Almarsson presents at UNSW RNA Institute Symposium in Sydney, Australia Read More Company News Örn Almarsson 8/1/24 Company News Örn Almarsson 8/1/24 Molecular Library Established via Combination of Acquired Assets and Internal Work Read More Company News Örn Almarsson 3/11/24 Company News Örn Almarsson 3/11/24 SSPC Collaboration Formally Announced Read More Company News Örn Almarsson 6/5/23 Company News Örn Almarsson 6/5/23 Axelyf’s first grant from the Icelandic Centre for Research Read More Media Örn Almarsson 5/6/23 Media Örn Almarsson 5/6/23 Örn Almarsson was interviewed in Iceland for The Iceland Monitor and discussed the founders' motivation and establishment of Axelyf Read More Company News Örn Almarsson 4/4/23 Company News Örn Almarsson 4/4/23 Multi-year collaboration to pursue chemistry and bio-analytical work for Axelyf’s pipeline projects Read More
Press Release, EIN Presswire Örn Almarsson 12/16/25 Press Release, EIN Presswire Örn Almarsson 12/16/25 ‘Axelyf Appoints Daniel Frímannsson, Ph.D., Head of Nucleic Acid Technologies & Biology and Leslie Williams to Board’ Read More
Press Release, EIN Presswire Örn Almarsson 8/19/25 Press Release, EIN Presswire Örn Almarsson 8/19/25 ‘Axelyf Closes Seed Financing to Advance Next-Generation RNA-LNP Therapeutics’ Read More
Media Örn Almarsson 5/27/25 Media Örn Almarsson 5/27/25 'Developing and delivering mRNA lipid nanoparticle therapeutics’ - BioTechniques Interview with Örn Read More
Media Örn Almarsson 3/28/25 Media Örn Almarsson 3/28/25 Örn Almarsson interviewed by Lucia Donajová from Synthace Read More
Media Örn Almarsson 2/3/25 Media Örn Almarsson 2/3/25 Örn Almarsson joins Charles Spence on ‘A Dose of Reality’ podcast Read More
Media Örn Almarsson 9/13/24 Media Örn Almarsson 9/13/24 Örn Almarsson presents at UNSW RNA Institute Symposium in Sydney, Australia Read More
Company News Örn Almarsson 8/1/24 Company News Örn Almarsson 8/1/24 Molecular Library Established via Combination of Acquired Assets and Internal Work Read More
Company News Örn Almarsson 3/11/24 Company News Örn Almarsson 3/11/24 SSPC Collaboration Formally Announced Read More
Company News Örn Almarsson 6/5/23 Company News Örn Almarsson 6/5/23 Axelyf’s first grant from the Icelandic Centre for Research Read More
Media Örn Almarsson 5/6/23 Media Örn Almarsson 5/6/23 Örn Almarsson was interviewed in Iceland for The Iceland Monitor and discussed the founders' motivation and establishment of Axelyf Read More
Company News Örn Almarsson 4/4/23 Company News Örn Almarsson 4/4/23 Multi-year collaboration to pursue chemistry and bio-analytical work for Axelyf’s pipeline projects Read More
